NUT midline carcinoma
Showing 1 - 25 of 8,060
NUT Midline Carcinoma (NMC), Triple Negative Breast Cancer (TNBC), NSCLC (NSCLC) Trial (Birabresib)
Terminated
- NUT Midline Carcinoma (NMC)
- +3 more
- (no location specified)
Jan 7, 2021
Metastatic Malignant Solid Tumor, Metastatic NUT Carcinoma, Unresectable Malignant Solid Tumor Trial (Abemaciclib, BET
Suspended
- Metastatic Malignant Solid Neoplasm
- +3 more
- Abemaciclib
- +3 more
-
Boston, MassachusettsDana-Farber - Harvard Cancer Center LAO
Sep 17, 2022
Castrate Resistant Prostate Cancer, NUT Carcinoma Trial (EP31670)
Not yet recruiting
- Castrate Resistant Prostate Cancer
- NUT Carcinoma
- (no location specified)
Aug 3, 2022
Tumors, NUT Carcinoma Trial in Worldwide (BI 894999)
Completed
- Neoplasms
- NUT Carcinoma
- BI 894999
-
Boston, Massachusetts
- +15 more
Dec 3, 2021
CNS Tumor, Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma Trial in Seattle (SCRI-CARB7H3(s); B7H3-specific chimeric
Recruiting
- Central Nervous System Tumor
- +10 more
- SCRI-CARB7H3(s); B7H3-specific chimeric antigen receptor (CAR) T cel
-
Seattle, WashingtonSeattle Children's Hospital
Dec 14, 2022
Triple-Negative Breast Cancer, High-grade Serous Ovarian Cancer, Solid Tumors Trial in United States (CUDC-907)
Completed
- Triple-Negative Breast Cancer
- +3 more
-
San Francisco, California
- +3 more
Aug 30, 2019
Metastatic NUT Carcinoma, Unresectable NUT Carcinoma Trial (Cisplatin, Etoposide, Etoposide Phosphate)
Withdrawn
- Metastatic NUT Carcinoma
- Unresectable NUT Carcinoma
- Cisplatin
- +4 more
- (no location specified)
Sep 25, 2020
Oral Cashew Nut Immunotherapy in Children (CAJESITO)
Not yet recruiting
- Allergy;Food
- Allergy, Nut
- No intervention
- (no location specified)
Apr 21, 2023
Food Allergy in Infants, Nut Allergy Trial in Melbourne (Home introduction, Multi Nut oral food challenge)
Recruiting
- Food Allergy in Infants
- Nut Allergy
- Home introduction
- Multi Nut oral food challenge
-
Melbourne, Victoria, AustraliaMurdoch Children's Research Institute (MCRI)
Dec 7, 2022
Infusing Irritant Medications Through Midline Catheter Based on
Recruiting
- Catheter Complications
-
Hangzhou, Zhejiang, ChinaLinfang Zhao
Jan 25, 2023
Efficacy and Safety of Cashew Nut Oral Immunotherapy in Children
Not yet recruiting
- Food Allergy in Children
- no intervention
-
Vandœuvre-lès-Nancy, FranceCentre Hospitalo-Universitaire de Nancy
Apr 7, 2023
Malnutrition, Healthy Aging, Dehydration Trial (Keep-on-Keep-Up Nutrition (KOKU-Nut))
Not yet recruiting
- Malnutrition
- +2 more
- Keep-on-Keep-Up Nutrition (KOKU-Nut)
- (no location specified)
Jul 4, 2023
Accidental Reactions in Peanut/Tree Nut Allergic Children
Recruiting
- Peanut and Tree Nut Allergy
-
Lille, FranceHop Jeanne de Flandre Chu Lille
Jan 2, 2023
Diffuse Midline Glioma, H3 K27M-Mutant, Diffuse Intrinsic Pontine Glioma, Diffuse Glioma Trial (Re-irradiation)
Not yet recruiting
- Diffuse Midline Glioma, H3 K27M-Mutant
- +5 more
- Re-irradiation
- (no location specified)
Oct 16, 2023
Intergluteal Cleft as Landmark for Neuraxial Midline in
Not yet recruiting
- Obstetric Anesthesia Problems
- Intergluteal Cleft
- +2 more
-
London, United KingdomGuy's Hospital, Great Maze Pond
Aug 8, 2023
Clinical Evaluation of the PowerGlide™ Pro Midline Catheter
Completed
- Pain
- Catheter Infection
- PowerGlide™ Pro Midline Catheter
-
Augsburg, GermanyUniversity Hospital Augsburg
Sep 7, 2023
Locally Advanced Nasopharyngeal Carcinoma Trial (Enteral immunonutrition, Standard enteral nutrition)
Not yet recruiting
- Locally Advanced Nasopharyngeal Carcinoma
- Enteral immunonutrition
- Standard enteral nutrition
- (no location specified)
May 29, 2023
Peanut Allergy, Nut Allergy Trial in Amsterdam (Immune-supportive diet)
Recruiting
- Peanut Allergy
- Nut Allergy
- Immune-supportive diet
-
Amsterdam, NetherlandsOLVG
Feb 1, 2023
Tobacco Smoking, Vaping, Tobacco Chewing Trial in Tiyan (School-based curriculum)
Recruiting
- Tobacco Smoking
- +2 more
- School-based curriculum
-
Tiyan, GuamGuam Department of Education
Aug 11, 2022
Head and Neck Carcinoma Trial in Cairo (Elective nodal de-escalation arm)
Recruiting
- Head and Neck Carcinoma
- Elective nodal de-escalation arm
-
Cairo, EgyptNational Cancer Institute
Dec 6, 2022